LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 3 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 3. - Dataset (ID:20311)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
|---|---|---|---|---|---|---|---|---|---|---|
| MCF 10A-H2B-mCherry | Dasatinib | 0.056667 | 57.18 | 84.90 | 448 | 6963 | 0.0643 | 0.2990 | MN20160318_Q02 | J17 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.056667 | 57.18 | 84.90 | 5374 | 6963 | 0.7718 | 0.9201 | MN20160318_Q02 | J17 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.056667 | 58.88 | 84.90 | 197 | 7291 | 0.0270 | 0.1400 | MN20160318_Q02 | E17 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.056667 | 58.88 | 84.90 | 4706 | 7291 | 0.6454 | 0.8682 | MN20160318_Q02 | E17 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.056667 | 58.88 | 84.90 | 473 | 7291 | 0.0649 | 0.3065 | MN20160318_Q02 | J17 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.056667 | 58.88 | 84.90 | 5617 | 7291 | 0.7703 | 0.9204 | MN20160318_Q02 | J17 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.056667 | 60.59 | 84.90 | 228 | 7641 | 0.0298 | 0.1644 | MN20160318_Q02 | E17 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.056667 | 60.59 | 84.90 | 4939 | 7641 | 0.6463 | 0.8700 | MN20160318_Q02 | E17 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.056667 | 60.59 | 84.90 | 401 | 7641 | 0.0525 | 0.2702 | MN20160318_Q02 | J17 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.056667 | 60.59 | 84.90 | 5886 | 7641 | 0.7702 | 0.9212 | MN20160318_Q02 | J17 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.056667 | 62.29 | 84.90 | 182 | 7934 | 0.0229 | 0.1236 | MN20160318_Q02 | E17 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.056667 | 62.29 | 84.90 | 5126 | 7934 | 0.6460 | 0.8709 | MN20160318_Q02 | E17 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.056667 | 62.29 | 84.90 | 402 | 7934 | 0.0507 | 0.2681 | MN20160318_Q02 | J17 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.056667 | 62.29 | 84.90 | 6107 | 7934 | 0.7697 | 0.9216 | MN20160318_Q02 | J17 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.056667 | 63.99 | 84.90 | 167 | 8212 | 0.0203 | 0.1080 | MN20160318_Q02 | E17 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.056667 | 63.99 | 84.90 | 5349 | 8212 | 0.6513 | 0.8741 | MN20160318_Q02 | E17 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.056667 | 63.99 | 84.90 | 359 | 8212 | 0.0437 | 0.2443 | MN20160318_Q02 | J17 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.056667 | 63.99 | 84.90 | 6352 | 8212 | 0.7735 | 0.9236 | MN20160318_Q02 | J17 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.056667 | 65.70 | 84.90 | 184 | 8484 | 0.0217 | 0.1235 | MN20160318_Q02 | E17 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.056667 | 65.70 | 84.90 | 5465 | 8484 | 0.6441 | 0.8719 | MN20160318_Q02 | E17 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.056667 | 65.70 | 84.90 | 371 | 8484 | 0.0437 | 0.2486 | MN20160318_Q02 | J17 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.056667 | 65.70 | 84.90 | 6548 | 8484 | 0.7718 | 0.9235 | MN20160318_Q02 | J17 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.056667 | 67.41 | 84.90 | 195 | 8766 | 0.0222 | 0.1324 | MN20160318_Q02 | E17 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.056667 | 67.41 | 84.90 | 5655 | 8766 | 0.6451 | 0.8732 | MN20160318_Q02 | E17 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.056667 | 67.41 | 84.90 | 357 | 8766 | 0.0407 | 0.2395 | MN20160318_Q02 | J17 |